Skangass Selects Linde to Build Mid-Scale LNG Import Terminal in Lysekil, Sweden

The technology company The Linde Group has been commissioned by Norwegian-based Skangass AS to build a mid-scale liquefied natural gas (LNG) import terminal at the west coast of Sweden, in Lysekil, 100 kilometres north of Gothenburg. The corresponding engineering, procurement, construction and installation (EPCI) contract is worth around EUR 44 m.

The works include the integration of the cryogenic tank structures to be erected by a third party. The new LNG terminal is planned to start operations in spring 2014 and will supply natural gas to the nearby Preem refinery as well as LNG for industrial and transportation applications.

"With this project we confirm our leading position in the growing small-to-mid-scale LNG market," said Professor Dr Aldo Belloni, Member of the Executive Board of Linde AG. "Also taking into account Sweden's first LNG terminal we completed last year in Nynäshamn, we see ourselves on the right course to strongly benefit from the trend towards LNG as a low-emission fuel and petroleum substitute."

The new terminal will have a storage capacity of 30,000 cubic metres (m³) of LNG, compared to 20,000 m³ at Nynäshamn, and will include a truck filling station. Linde Engineering has performed the basic engineering and will support with the procurement of rotating equipment, commis¬sioning and start-up. LNG for both terminals - Nynäshamn and Lysekil - comes from the mid-scale LNG plant at Risavika near Stavanger, Norway. This plant - also built for Skangass by Linde - started operations in 2010.

Nearby Gothenburg is one of Sweden's key industrial areas and northern Europe's largest port of export. It is located in a so-called "Emission Control Area" (ECA), where stricter sulphur emission limits will become applicable in January 2015. LNG offers a reliable and economical solution to a wide range of applications and will help to comply with the upcoming regulations.

Only in October the newly founded joint venture company Bomin Linde LNG (BLLNG) announced to start planning a small-scale LNG terminal in Hamburg - another port that will be subject to stricter emission limits from 2015 on. BLLNG is a joint venture of Marquard & Bahls subsidiary Bomin, a leading provider of marine fuels, and Linde. The declared strategy of Bomin Linde LNG is to cover the complete LNG value chain - from purchasing and transport through storage to distribution and refuelling of ships at strategically important ports.

The Linde Group is a world-leading gases and engineering company with around 62,000 employees in more than 100 countries worldwide. In the 2011 financial year, Linde generated revenue of EUR 13.787 bn. The strategy of the Group is geared towards long-term profitable growth and focuses on the expansion of its international business with forward-looking products and services. Linde acts responsibly towards its shareholders, business partners, employees, society and the environment - in every one of its business areas, regions and locations across the globe. The Group is committed to technologies and products that unite the goals of customer value and sustainable development.

Under the "Clean Technology by Linde" label, the company offers a wide range of products and techno¬logies that help to render renewable energy sources financially viable, and significantly slow down the deple¬tion of fossil resources or reduce the level of CO2 emitted. This ranges from specialty gases for solar module manufacturing, industrial-scale CO2 separation and application technologies to alternative fuels and energy carriers such as liquefied natural gas (LNG) and hydrogen.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.